celastrol has been researched along with ccg 50014 in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (ccg 50014) | Trials (ccg 50014) | Recent Studies (post-2010) (ccg 50014) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 10 | 0 | 9 |
| Protein | Taxonomy | celastrol (IC50) | ccg 50014 (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.19 | |
| Regulator of G-protein signaling 4 | Homo sapiens (human) | 0.0301 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodle, CR; Doorn, JA; Hayes, MP; Henry, MD; Houtman, JCD; James, MA; Mackie, DI; Miller, MR; Roman, DL; Schamp, JH | 1 |
1 other study(ies) available for celastrol and ccg 50014
| Article | Year |
|---|---|
Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell Lines.
Topics: Benzophenanthridines; Biological Products; Cytostatic Agents; Cytotoxins; GTP-Binding Protein Regulators; Humans; Isoquinolines; Lung Neoplasms; Male; Molecular Structure; Pentacyclic Triterpenes; Prostatic Neoplasms; Triterpenes | 2017 |